[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-NBIX":3,"stock-news-NBIX":31,"homepage-market-summary":139},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"NBIX","2026-10-06",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Neurocrine Biosciences Inc","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.","2,500","San Diego, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},145.51,145.56,145.77,141.39,144.21,1.3,0.9,1382312.264367,21694,144.6145,186.12,122.14,1163288.0954105258,36.5,7640,{"ticker":4,"count":32,"articles":33},19,[34,40,46,52,58,64,70,75,80,86,92,98,103,108,113,118,123,128,133],{"title":35,"link":36,"pubDate":37,"description":38,"source":39},"NEUROCRINE BIOSCIENCES INC (NBIX) Stock Chart - ChartMill","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZEFVX3lxTFB4TWdGYmo5N01lVF9hc2tfcXFpWkNQZjExcXpxNGZyT0JJeHpEbF9GYnVIbjY0SmVsOVptSWNxSFduMHJJQy1CRzVfcFVrRE0wYW1zLXdPcWNlR1QxeWVSS0g2dEQ?oc=5","Sat, 03 Oct 2026 00:19:59 GMT","NEUROCRINE BIOSCIENCES INC (NBIX) Stock Chart ChartMill","ChartMill",{"title":41,"link":42,"pubDate":43,"description":44,"source":45},"After 26 years at Eli Lilly, Eiry Roberts returns to Neurocrine as its chief medical officer. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxNRjZ6dWZlMWd1WUJyUnhIeXctU1lVM1ZwMTYyVWI2YnN6OGlUZGdRVHBjTDN3NkxrNk5IeFVIY0FvQms3djlzWU9JN1Bab2xHRkdsYXJqRWlCZEFUdWhxMFB5bFgxdmc5MFlfWENPOU56RkpaMHVUZzI2NUNMLVZiOEtqM3lYdUY0bTl2dTdGVFRtNjFnQmdZSktCWXE5SVdWcmhVTFlLMm0yMV9qUm9vZTlxTThHQ3hiT3lZbGVEaw?oc=5","Mon, 28 Sep 2026 20:05:00 GMT","After 26 years at Eli Lilly, Eiry Roberts returns to Neurocrine as its chief medical officer. Stock Titan","Stock Titan",{"title":47,"link":48,"pubDate":49,"description":50,"source":51},"Neurocrine Biosciences, Inc. (NBIX) Stock Forecasts - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxOWDJZVGdpRVFVLTZKUTUzSFgySXVHY1o5LVZUcHNTNm01NDJVUGtfeUhLWUlveDhJcGdwMWFPOFhDVVNrdjZPcFg2SkFhZENWeHRtR0VWVWp5Szd2WXBMUUwxUUgxdl9EMzlEVEZDRm5FVUl5ejdGWVE0ZEhpem80R1U5UGx5U28wVWhNZmJtVQ?oc=5","Thu, 01 Oct 2026 17:11:11 GMT","Neurocrine Biosciences, Inc. (NBIX) Stock Forecasts Yahoo Finance","Yahoo Finance",{"title":53,"link":54,"pubDate":55,"description":56,"source":57},"(NBIX) Movement as an Input in Quant Signal Sets - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxQQ0dvd3haVVJFOUxDQUluemU1MW5idFduNURwbkJNT0lqLTNKWDg3X05DRGQzcTdJaXByMGRHUjM0ZDFrUHF0SUZ2bHdGeGJFNjZNbk1CalVsTnhJdV9pUjFJbmZkYnE0Tm5RM3VRcmNpQ2J6LWNPMktEdGVhSnJtNUNQcUtxWG1EbmtvczNQdzJEeDhhd3NqSGlMRGNKU1VxUVZXLWpFNWx1T3NGYmdCb1VOVnNZRkswN3BScnViblpJNThp?oc=5","Sat, 03 Oct 2026 00:42:02 GMT","(NBIX) Movement as an Input in Quant Signal Sets Stock Traders Daily","Stock Traders Daily",{"title":59,"link":60,"pubDate":61,"description":62,"source":63},"Neurocrine Biosciences (NBIX) Ticks Higher: Shares Gain 1.76% to $143.18 - Cash Secured Put - https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxQUW5LMmVkUUIzS0txcWN5Y2JoTms2X0FKWVhuLXBfaF83WldVT2FoQW9jeHRNQWFiUmdaT2tnRXlZVFNobFFCeVpGZjhBeDd6aUNkSWpuZ214WXRvMUt0am43RDI2LVZHZVk1TzNLeFJwUjhhVmJJU04wdTdEaDk0Z2k2M3RpbVdUbTdzYjNDckNJdGcxdC1fV2duUE0zZE1PdFI5aUZ3N1VoaGFY?oc=5","Sat, 03 Oct 2026 11:35:17 GMT","Neurocrine Biosciences (NBIX) Ticks Higher: Shares Gain 1.76% to $143.18 - Cash Secured Put https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fwww.siam.in\u002F",{"title":65,"link":66,"pubDate":67,"description":68,"source":69},"Neurocrine Biosciences (NBIX) Could Be 34% Undervalued After Its CMO Return - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Tue, 29 Sep 2026 07:00:00 GMT","Neurocrine Biosciences (NBIX) Could Be 34% Undervalued After Its CMO Return Simply Wall Street","Simply Wall Street",{"title":71,"link":72,"pubDate":73,"description":74,"source":45},"Studies will track real-world use of a treatment for intense hunger and hear from caregivers. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxOYU04ZzV2b1ljZkxSRGs2SF9zWEdGY3lxZlN6dWdydkVVVHhSLVh3WWpOUnVDVFVZZFU4dHlYQTBrNFlOWHdWRDJhQzJhdEh1WU05ZXVpYkVPb1U1bS1FdkVQcWlnaUszQzNBdzZ6TFhMenI0QXZsbXlzQ1dEUE9CWTZvVFMtMkNEeEN2LVY5SW85OERKdm9JZ3cxdFdLY19QbEYzd09qcVN2TlllamMzYkI3ZHFuVHVzaDdnM0VR?oc=5","Wed, 30 Sep 2026 12:30:00 GMT","Studies will track real-world use of a treatment for intense hunger and hear from caregivers. Stock Titan",{"title":76,"link":77,"pubDate":78,"description":79,"source":39},"Neurocrine Biosciences (NASDAQ:NBIX) Stands Out as a Decent Value Stock - ChartMill","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxPcWQ4SFl4ejRrVXRIWl91QlRCSzZkRDByOFVDNVJ3cHBvRWxvQjEzaThBTnh4VTZYQ0NUYTl2Tm1fMnJLQ1RKMlFWaEtUcGFsbkZMSkYwVDR4MWRwQXlYUWoxakx4VWh0Sm5uQ0plOTJrcWFuUWxRS1NSWVo5dG1FYWVtaEhNN0dnWmV5TFR1SEdSR0lybjhaMlFNRnA4WWNYMzUxeHlsMFlKRmV6RWxsZkVkZnFwb0lKU29hcg?oc=5","Mon, 05 Oct 2026 11:51:00 GMT","Neurocrine Biosciences (NASDAQ:NBIX) Stands Out as a Decent Value Stock ChartMill",{"title":81,"link":82,"pubDate":83,"description":84,"source":85},"Neurocrine names Roberts CMO. Neurocrine Biosciences stock sits 23.07 percent below its high - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxQT2N6V3A5MFY5M3VQUzdyZTAxNHRRNV9tQnZPNVctNzNWSzR3dFBfMC04MHdubkpmbWQwV3pBaTFFSXNBZEFOeE04alJyNEpudWJpTERqejk2VXd5eXNBOFAyQXJIMER1alZpQmQxS2VOVTJZcHdmc2RCV1JUbnllSWhYbThaR280UU1wUDZmRFR6Skt4X0hqM29zWjRJbjdPNzB1TUFEdFRkNVB0dU5WWWtYcUFFcF9aZ3YwbzhxbzR5X3kzVUE?oc=5","Mon, 05 Oct 2026 07:00:21 GMT","Neurocrine names Roberts CMO. Neurocrine Biosciences stock sits 23.07 percent below its high AD HOC NEWS","AD HOC NEWS",{"title":87,"link":88,"pubDate":89,"description":90,"source":91},"Neurocrine Biosciences names Eiry Roberts as chief medical officer By Investing.com - Investing.com South Africa","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxPSnhzSU85QzZZRGlJNElXcEVuNmlIcEFLNnJWeUN4NWE1dFlHVld4el8xX0V1OVFkRmR4RjdUVzlibmZMUDU5RTBzSURMcnZXdzBUQjRmaVJ0eDFyOHBrYmRyMUVLZ1g5d0Q4RFluOU1hdnJadXRlczgwNjItZm1UcmlFRVZwTU1GRjRxb1ppc2ZXOWc5cThoaXRkUl9xbjJCcmlIODFyTjdzTWptakhia01xWGRENEFmbmEwMHZCNWo5ZzZJYkE?oc=5","Mon, 28 Sep 2026 21:25:23 GMT","Neurocrine Biosciences names Eiry Roberts as chief medical officer By Investing.com Investing.com South Africa","Investing.com South Africa",{"title":93,"link":94,"pubDate":95,"description":96,"source":97},"Teva Pharmaceutical Industries Limited (TEVA) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiYkFVX3lxTFBUSDN4Wm9rT0czYWRLeDRyVmUzMTZrZ2FWMGx2U25RcG1nbGpYWmtodWhoeUt2cGRFaFRDT2ptLXdQU1c3TnNqamNnQnRoRXRBRGFqRmNqT3NnenB2VzZVT2xn?oc=5","Fri, 02 Oct 2026 04:30:30 GMT","Teva Pharmaceutical Industries Limited (TEVA) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":99,"link":100,"pubDate":101,"description":102,"source":69},"Neurocrine Biosciences (NBIX) After New VYKAT XR Data Why The Undervalued Narrative Persists - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 07 Oct 2026 10:58:17 GMT","Neurocrine Biosciences (NBIX) After New VYKAT XR Data Why The Undervalued Narrative Persists Simply Wall Street",{"title":104,"link":105,"pubDate":106,"description":107,"source":45},"Neurocrine names Eiry Roberts chief medical officer - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxPa1o3YTNGb28wYzE4Ti1uSEJBbUZIWWVFaE9LcEtMMlNmVnZtakYtR0poOW4xZXN0NTNTSklmN1JCdEZDQng0QnRJaE91MklLQlFRUnRYLUphUzU0eU0wV0dIa29XUWVZZC1HQi1NWENnRlZURmxsUHJ1U2ZuTHVpb0IzTmtCSm8wTXpOR3NkcTVCRDVUZ2xoTnB4NU5KWVVHdktMVjg0OXc2ckFET0dBYWt5bG1RZw?oc=5","Mon, 28 Sep 2026 20:21:27 GMT","Neurocrine names Eiry Roberts chief medical officer Stock Titan",{"title":109,"link":110,"pubDate":111,"description":112,"source":39},"Neurocrine Biosciences (NASDAQ:NBIX): Affordable Growth at a Reasonable Valuation - ChartMill","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxPdk9xS1l0NEFGeUczZ3ZVc2IxZ182NFhuZUE2bzJqYWkwOVk1MmRRSHNHZVozczVJNHZQOG9wMXNCUFFtaktSb2lfQ2wwamY1RF9HQUgwOVdyLUZTaUk4V0g1czNPTll4UDREYUtjMnB1SnNCUmFmSnMxT2oxNGFuWDhrdklJdW5pUWs3VGV6VW83RTJaRlcwMlVJMkFNd2xzb0pWMW5NZXBYa3JTSjVXd3hGWHFVYUhYeW05ZGlZQVI4Z2llQVNLTg?oc=5","Fri, 02 Oct 2026 10:00:42 GMT","Neurocrine Biosciences (NASDAQ:NBIX): Affordable Growth at a Reasonable Valuation ChartMill",{"title":114,"link":115,"pubDate":116,"description":117,"source":85},"Neurocrine Biosciences stock fell 1.4 percent before research event - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxPbDZka25kZjQ0RXkwZHloV1A3V1hvZXY1bWlpWWozdzhEQUxKc2Z0RTZ4dTc1Q2FDRExxUlF5eEhzWUVaSDgxVHVHR3BINjNFbWtHUGlERmFpZlptYlVoUUZaMmRKbXBIR29wT2ZpTklwS0pDY1dLcU9jS3ZZcHU0OXMzY2ZIMnRoOGNuUklNc3AtWGIwZFVieHhZb0lPV0FfU0lUMGV2Y1k2MXB3RWE4R3ZzTUo3QjNGMEtFenhnVXFqZlZ0?oc=5","Wed, 07 Oct 2026 04:21:33 GMT","Neurocrine Biosciences stock fell 1.4 percent before research event AD HOC NEWS",{"title":119,"link":120,"pubDate":121,"description":122,"source":69},"NBIX: Core Growth Looks Intact, Execution Still Holds The Key - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 01 Oct 2026 07:00:00 GMT","NBIX: Core Growth Looks Intact, Execution Still Holds The Key Simply Wall Street",{"title":124,"link":125,"pubDate":126,"description":127,"source":63},"NBIX Q2 2026 Earnings: EPS Tops Estimate as Shares Gain 2.52% - Analyst Consensus Shift - https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxNMUZnYjJyNXc1NnM4RjZTVnVMOEItUkxJZ2E1a0ZDVzI3eGQ0LXhmeDU4MHpzWTJZQXBhcnFzNXd1SC1qMXhxZ09mei1DTmY2S09nZUhKQVhVUjVDMUEwS0M0ZGw2ZXQ3S1lod1JKNkF1cWRVbS1JZU00Uk5OcHlIVE44ckYyZS1vR1p2ZHhmYlVWVGcwa0NGTkVfYkNpN2dzbVow?oc=5","Thu, 01 Oct 2026 00:33:16 GMT","NBIX Q2 2026 Earnings: EPS Tops Estimate as Shares Gain 2.52% - Analyst Consensus Shift https:\u002F\u002Fwww.siam.in\u002F",{"title":129,"link":130,"pubDate":131,"description":132,"source":85},"Neurocrine names Eiry W. Roberts CMO and Neurocrine Biosciences stock gains 1.74 percent - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3wFBVV95cUxOSFo3N1RIcTdzSHFqYWtSNC1GMFFjUkZCSGt6NUlMTkwwZ0JLNjA2LWl0dlBzZ1cyNXhXOE5SUVctV3J2YmJLQUw5b0M3N2ZZOTBoN2RFbDlqUzhZRUhCQVRTZ183MUd1WjQ2VXZCN0VqWHByaVBQYTRSVkprN1BsZzVCVWRkb3JyUnFWTjdKbmNpRUVBNGc4RWc4S2g5OF95Xy1VLVJYbUxUUDlUS05TcmlRNlJRUDRUWmJNSVcxMk01N2EzX1VkUU5yMTVqWW5IZll0VURqalN1a3Q4X1RR?oc=5","Fri, 02 Oct 2026 19:52:04 GMT","Neurocrine names Eiry W. Roberts CMO and Neurocrine Biosciences stock gains 1.74 percent AD HOC NEWS",{"title":134,"link":135,"pubDate":136,"description":137,"source":138},"Neurocrine Names Eiry Roberts as New Chief Medical Officer - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxQRWt1bkVSUlZ1amVQVFFLeTRUcGlfQTNpZ0VNVkNhZ3M1cTQxMzY5NW1MRHJWTjcyOXphZDhETGgxOXRtdXU2WkRuMFJkVDdWbWlqenJHRzdzSlpzTEdZWFdWcktfYmZhZXJDbEI5WUszYVhlMllBZVJGeWdMQmpQcmh2WVA5VDBZQXF1S0JDUk00dDZjYmgwY1VjNTJYZU8xdUdGYjhlQXFDaEZLZnBR?oc=5","Mon, 28 Sep 2026 07:00:00 GMT","Neurocrine Names Eiry Roberts as New Chief Medical Officer TipRanks","TipRanks",{"status":140,"indices":141,"watchlist":185,"sectors":207,"benchmarks":262},"success",[142,150,157,164,171,178],{"symbol":143,"name":144,"price":145,"change":146,"pct_change":147,"is_up":148,"sparkline":149,"date":5},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0",{"symbol":151,"name":152,"price":153,"change":154,"pct_change":155,"is_up":148,"sparkline":156,"date":5},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":158,"name":159,"price":160,"change":161,"pct_change":162,"is_up":148,"sparkline":163,"date":5},"DJI","DOW JONES",51521,253,0.49,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":165,"name":166,"price":167,"change":168,"pct_change":169,"is_up":148,"sparkline":170,"date":5},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":172,"name":173,"price":174,"change":175,"pct_change":176,"is_up":14,"sparkline":177,"date":5},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":179,"name":180,"price":181,"change":182,"pct_change":183,"is_up":14,"sparkline":184,"date":5},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[186,193,200],{"symbol":187,"name":188,"price":189,"change":190,"pct_change":191,"is_up":148,"sparkline":192,"date":5},"NVDA","NVIDIA Corp",239.24,0.34,0.14,"0.0,14.1 7.3,16.0 14.7,14.6 22.0,11.8 29.3,8.2 36.7,2.4 44.0,2.0",{"symbol":194,"name":195,"price":196,"change":197,"pct_change":198,"is_up":148,"sparkline":199,"date":5},"AAPL","Apple Inc",333.63,0.74,0.22,"0.0,2.0 7.3,16.0 14.7,10.4 22.0,14.6 29.3,9.3 36.7,10.6 44.0,9.4",{"symbol":201,"name":202,"price":203,"change":204,"pct_change":205,"is_up":148,"sparkline":206,"date":5},"TSLA","Tesla Inc",380.68,1.95,0.51,"0.0,13.7 7.3,16.0 14.7,15.0 22.0,15.4 29.3,7.1 36.7,3.0 44.0,2.0",[208,213,218,223,228,232,237,242,247,252,257],{"name":209,"etf":210,"change":211,"price":212,"is_up":148},"Technology","XLK",0.53,202,{"name":214,"etf":215,"change":216,"price":217,"is_up":148},"Financials","XLF",0.24,54.01,{"name":219,"etf":220,"change":221,"price":222,"is_up":14},"Healthcare","XLV",-0.17,167.09,{"name":224,"etf":225,"change":226,"price":227,"is_up":148},"Consumer Cycl","XLY",1.2,111.75,{"name":229,"etf":230,"change":22,"price":231,"is_up":148},"Consumer Staples","XLP",81.77,{"name":233,"etf":234,"change":235,"price":236,"is_up":148},"Energy","XLE",0.47,63.75,{"name":238,"etf":239,"change":240,"price":241,"is_up":148},"Industrials","XLI",0.87,171.58,{"name":243,"etf":244,"change":245,"price":246,"is_up":148},"Materials","XLB",0.46,49.73,{"name":248,"etf":249,"change":250,"price":251,"is_up":148},"Real Estate","XLRE",1.06,41.1,{"name":253,"etf":254,"change":255,"price":256,"is_up":148},"Utilities","XLU",2.98,41.16,{"name":258,"etf":259,"change":260,"price":261,"is_up":148},"Comm Services","XLC",0.04,111.65,[263,268,272,276],{"ticker":264,"name":265,"price":266,"change":267,"is_up":148},"SPY","SPDR S&P 500 ETF",779.09,0.55,{"ticker":269,"name":270,"price":271,"change":245,"is_up":148},"QQQ","Invesco QQQ Trust",759.69,{"ticker":273,"name":274,"price":275,"change":155,"is_up":148},"DIA","SPDR Dow Jones ETF",514.56,{"ticker":277,"name":278,"price":279,"change":280,"is_up":14},"IWM","iShares Russell 2000",281.37,-0.71]